Management of Tubular Adenomas to Prevent Colorectal Cancer

Risk Stratification Based on Baseline Colonoscopy Findings

Patients with 1-2 small tubular adenomas with low-grade dysplasia should undergo their next surveillance colonoscopy in 7-10 years, as recommended by the American Gastroenterological Association, based on evidence showing low risk of advanced neoplasia in this group 1, 2, 3
Patients with 3-4 tubular adenomas <10 mm should have their next colonoscopy in 3-5 years, according to the American Gastroenterological Association guidelines, allowing clinicians to consider individual patient factors when determining the exact interval 1, 2, 3, 4
Patients with any of the following high-risk findings should have their next colonoscopy in 3 years: adenoma ≥10 mm in size, adenoma with tubulovillous or villous histology, adenoma with high-grade dysplasia, or 5-10 adenomas <10 mm, as recommended by the American Gastroenterological Association 1, 2, 3, 4

If the first surveillance colonoscopy is normal or shows only 1-2 small tubular adenomas with low-grade dysplasia, the interval for subsequent examination should be extended to 5-10 years, based on guidelines from the American Cancer Society 4, 5
If high-risk adenomas are detected at the first surveillance examination, a 3-year interval is recommended by the American Cancer Society 4, 8

A high-quality baseline colonoscopy is essential for effective risk stratification, including complete examination to the cecum, adequate bowel preparation, minimum withdrawal time of six minutes, and complete removal of all detected neoplastic lesions, as emphasized by the American Academy of Family Physicians 7, 9
Patients with sessile adenomas removed piecemeal should have a short-interval follow-up (6 months) to verify complete removal, as recommended by the American Cancer Society 4, 7

The 2020 US Multi-Society Task Force guidelines represent the most recent evidence-based recommendations, with several key updates from previous guidelines, including the extended interval (7-10 years) for low-risk adenomas, which is based on evidence showing very low risk of colorectal cancer in this group 1, 2, 3, 7